Filing Details

Accession Number:
0001144204-14-074864
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-18 21:44:39
Reporting Period:
2014-12-16
Filing Date:
2014-12-18
Accepted Time:
2014-12-18 21:44:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001316 Tg Therapeutics Inc. TGTX Pharmaceutical Preparations (2834) 363898269
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1038977 S Michael Weiss 3 Columbus Ave, 15Th Floor
New York NY 10019
See Remarks Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-12-16 210,618 $16.44 8,120,773 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. In connection with the vesting of 375,000 shares on December 15, 2014, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Weiss' tax withholding obligations. Mr. Weiss had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  2. Weighted average sales price of sales from 12/16/14 to 12/18/14.
  3. Includes shares of restricted Common Stock, which vest over various time periods. Includes 33,334 warrants to purchase Common Stock at $2.25, exercisable through December 31, 2016. Finally, also included in Mr. Weiss' beneficial ownership are 4,524,560 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest.